首先恭贺中国农业大学使用恒远生物自主品牌ELISA试剂盒在《Molecular Cancer》权威期刊上发表的SCI文献——A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triplenegative breast cancer顺利通过，IF影响因子高达37.3分！其次恭喜成功赢取了恒远生物奖学金，同时感谢对我司产品的认可，希望以下文献能帮助大家了解目前研究进展及我们的核心技术，欢迎各位老师联系我们咨询、提出意见，愿我们的努力成果与您的科研碰撞出不一样的火花！服务热线：400-0899-208
恒远生物自主研发ELISA试剂盒，现已涵盖20多个种属，数千种产品，涉及肿瘤、激素、自身免疫、心血管、代谢等十多个研究领域。其ELISA试剂盒不仅检测指标丰富，还可以根据实验需求定制检测范围，并且提供实验外包与免费代测服务。
恒远产品文献:人B细胞淋巴瘤因子2(Bcl-2)ELISA试剂盒引用文献
【文献标题】A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triplenegative breast cancer
【作者单位】中国农业大学(China Agricultural University)
【文献中引用产品】
人B细胞淋巴瘤因子2(Bcl-2)ELISA试剂盒
【关键词】TNBC, CircCAPG, CAPG-171aa, STK38, MEKK2, SLU7, Therapeutic target
【DOI】doi.org/10.1186/s12943-023-01806-x
【影响因子(IF)】37.3
【出版期刊】《Molecular Cancer》
【产品原文引用】Western blotting was performed by anti-MEKK2 (Proteintech, 55106-1-AP), MEK1/2 (ABclonal, A4868), SMURF1 (Bioss, bs-9391R), STK38 (Huabio, ER60144), ERK1/2 (Proteintech, 11257-1-AP), UB (Cell Signaling Technology, #3936), Phospho-MEK1/2 (Ser221) (Cell Signaling Technology, #2338), Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (Cell Signaling Technology, #8544), CAPG (Bioss, bsm-60,451 M), CDK4 (AtaGenix Laboratories Co., Ltd.(Wuhan), Wuhan, PR China, PA9437H), Cyclin D1 (Yeasen, 30026ES50), BCL2 (Shanghai hengyuan biological technology co., LTD, A-01203), CAPG (Proteintech, 10194-1-AP), FLAG (SMART, /smart-lifesciences, SLAB0101), HA (Yeasen, 30702ES20), HIS (Yeasen, 30401ES10). β-ACTIN, GAPDH, or TUBULIN (Proteintech, USA) were used as loading controls. All antibodies were diluted as required by the manufacturer (New Cell & Molecular Biotech, WB100D).
完整版PDF文献请咨询在线客服或者电话联系我司业务员！
更多公司福利请关注“恒远生物”微信公众号！
或访问恒远生物官网（http://www.hnybio.com）
